| 000 | 01717 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250513190754.0 | ||
| 264 | 0 | _c19990824 | |
| 008 | 199908s 0 0 eng d | ||
| 022 | _a0003-2999 | ||
| 024 | 7 |
_a10.1097/00000539-199908000-00033 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPöyhiä, R | |
| 245 | 0 | 0 |
_aSystemic physostigmine shows antiallodynic effects in neuropathic rats. _h[electronic resource] |
| 260 |
_bAnesthesia and analgesia _cAug 1999 |
||
| 300 |
_a428-33 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAnalgesics _xadministration & dosage |
| 650 | 0 | 4 |
_aAnalgesics, Opioid _xadministration & dosage |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAtropine _xpharmacology |
| 650 | 0 | 4 |
_aCholinergic Antagonists _xpharmacology |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aInjections, Subcutaneous |
| 650 | 0 | 4 | _aLigation |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMecamylamine _xpharmacology |
| 650 | 0 | 4 |
_aMorphine _xadministration & dosage |
| 650 | 0 | 4 |
_aNaloxone _xpharmacology |
| 650 | 0 | 4 |
_aNarcotic Antagonists _xpharmacology |
| 650 | 0 | 4 |
_aPain _xdrug therapy |
| 650 | 0 | 4 | _aPain Measurement |
| 650 | 0 | 4 | _aPain Threshold |
| 650 | 0 | 4 |
_aPeripheral Nervous System Diseases _xcomplications |
| 650 | 0 | 4 |
_aPhysostigmine _xadministration & dosage |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 | _aSpinal Nerves |
| 700 | 1 | _aXu, M | |
| 700 | 1 | _aKontinen, V K | |
| 700 | 1 | _aPaananen, S | |
| 700 | 1 | _aKalso, E | |
| 773 | 0 |
_tAnesthesia and analgesia _gvol. 89 _gno. 2 _gp. 428-33 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00000539-199908000-00033 _zAvailable from publisher's website |
| 999 |
_c10397519 _d10397519 |
||